SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 25.27 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 10.16 |
| Book Value / Share | 0.88 |
| Price / Book | n/a |
| NCAV ($M) | 6.96 |
| NCAV / Share | 0.60 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.29 |
| Return on Assets (ROA) | -0.25 |
| Return on Equity (ROE) | -0.27 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.53 |
| Current Ratio | 21.53 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.71 |
| Assets | 10.91 |
| Liabilities | 0.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Choo Chee Kong | 38.89 | -3.55 | |
| 13G | Zeng Jieming | 5.11 | 0.00 | |
| 13G | mDR Ltd | 11.59 | 0.00 | |
| 13G | Wang Shu | 7.66 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,003 | 2,686 | 37.34 | |
| 1,632 | 2,852 | 57.22 | |
| 4,849 | 15,589 | 31.11 | |
| 2,223 | 10,896 | 20.40 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FLGC – Flora Growth Corp. | FTLF – FitLife Brands, Inc. |
| GALT – Galectin Therapeutics Inc. | GELS – Gelteq Limited |
| GLMD – Galmed Pharmaceuticals Ltd. |
Financial data and stock pages provided by
Fintel.io